It took Evoke Pharma two years and a couple rounds of fundraising to slice and pull the data for an NDA of its only drug out of a Phase III wreckage. But just a month before the FDA was slated to give its verdict, the biotech reported that the effort m… […]
San Diego-based Adamis has stumbled in its attempt to get a lower-cost erectile dysfunction drug on the market.
The specialty pharmaceutical company ? which focuses on developing cheaper drugs for various disorders ? said the FDA had deemed its marketi… […]